Clindamycin - Benzoyl Peroxide
Pricing Report NDC 66993-949-45

Latest NADAC: $1.13253 per GM · Effective Aug 18, 2021 · Est. package price $50.96 (45 GM)

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Clindamycin - Benzoyl Peroxide (NDC 66993-949-45) is $1.13253 per GM. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Aug 18, 2021.

As a provided by Prasco Laboratories, this medication is distributed in a 1 TUBE in 1 CARTON / 45 g in 1 TUBE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$1.13253
Per GM

Effective Date
Aug 18, 2021
Billable Units
45 GM
Estimated Package Price
$50.96
Data Status
As of Aug 18, 2021
C/I - Chain or Independent Pharmacy
Package NDC
Description
1 TUBE in 1 CARTON / 45 g in 1 TUBE
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The NADAC was calculated based on package size.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Nov 2013, the NADAC wholesale price for (NDC ) has moved within a range of $0.83775 to $3.43107 per GM. Over this 7 years and 8 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.8378 - $3.4311
Market Volatility
309.56% Variance
Latest Trend
1.31%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Aug 18, 2021 $1.13253 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jul 21, 2021 $1.11787 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jun 23, 2021 $0.85108 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
May 19, 2021 $1.06032 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Apr 21, 2021 $0.91382 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Mar 17, 2021 $0.88273 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Feb 17, 2021 $0.83775 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jan 20, 2021 $0.89796 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Dec 23, 2020 $1.04014 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Nov 18, 2020 $1.20407 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Oct 21, 2020 $0.96993 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Sep 23, 2020 $0.85870 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 5: The NADAC was calculated based on package size.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: October 07, 2026